Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of GPO-A-FLU vs Tamiflu oral suspension in healthy adults under fasting conditions
TCTR20191211002Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on TCTR20191211002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191211002.